Eli Lilly's Path to the Next Trillion Market Capitalization

Eli Lilly and Company TodayLLYEli Lilly and Company $945.17 -7.57 (-0.79%) 52-Week Range$ 516.57▼ $972.53Dividend Yield0.55%P/E Ratio139.20Price Target$ 956.88Add to WatchlistEli Lilly and Co. NYSE: LLY is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, known as Mounjaro for type 2 diabetes, and Zepbound for obesity. Its stock is trading back near its all-time high at $972.52. Its market capitalization hovers around the$ 857 billion mark. The company has many growth ...